OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2023-03-31-accounts

Company Registration No. 06853971 Charity No. 1134589

British and Irish Association of Stroke Physicians

Company Limited by Guarantee

Unaudited financial statements for the year ended 31 March 2023

British and Irish Association of Stroke Physicians Company Limited by Guarantee Contents

Page
Trustees' annual report 1 - 8
Independent examiner's report 9
Statement of financial activities (including Income and Expenditure account) 10
Statement of financial position 11
Notes to the financial statements 12-18

British and Irish Association of Stroke Physicians Company Limited by Guarantee Trustees' Annual Report (Incorporating the Director's Report) For the year ended 31 March 2023

The trustees, who are also the directors for the purposes of company law, present their report and the unaudited financial statements of the charity for the year ended 31 March 2023.

Reference and administrative details

Registered charity name British and Irish Association of Stroke Physicians
Company number 06853971
Charity number 1134589
Trustees Dr Elizabeth Warburton
Professor Rustam Al-Shahi Salman
Professor Gillan Mead
Professor David Werring
Dr Ganesh Subramian
President Professor Gillian Mead
Secretary Dr Ganesh Subramian
Registered office 71 Queen Victoria Street
London
England
EC4V 4BE
Principle office Fitwise Management Limited
Blackburn House
Seafield
West Lothian
EH47 7AQ
Bankers Bank of Scotland Plc
43 Comely Bank
Edinburgh
EH4 1AF
Independent examiner Kenneth McDowell CA
Saffery Champness LLP
Edinburgh Quay
133 Fountainbridge
Edinburgh
EH3 9BA

1

British and Irish Association of Stroke Physicians Company Limited by Guarantee Trustees' Annual Report (Incorporating the Director's Report) (continued) For the year ended 31 March 2023

Structure, governance and management

British Association of Stroke Physicians (BASP) was set up in April 1999 to promote better care for people with stroke in the UK. In December 2021 BASP became BIASP (British and Irish Association of Stroke Physicians) following consultation with membership and ratification at the 2021 AGM to include the Republic of Ireland. The five objectives of BIASP are:

•Clinical Standards

•Teaching & Training •Research •External Engagement •Administra�on of the Associa�on

BIASP, formerly know as BASP, is a charitable company limited by guarantee (Company No. 06853971), incorporated on 20 March 2009, and registered as a charity on 02 March 2010. The company was established under a Memorandum of Association, which established the objects and powers of the charitable company and is governed under its Articles of Association. In the event of the company being wound up, members are required to contribute an amount not exceeding £1. The charitable company operates from the following address:

Blackburn House Redhouse Road Bathgate West Lothian EH47 7AQ

BIASP Executive Committee April 2022 to March 2023: •President: Professor Gillian Mead – Dec 2021 – March 2022

•Past President: Professor Rustam Al-Shahi Salman Dec 2021 – Dec 2023

•President Elect: Professor David Werring Dec 2021 – Dec 2023

•Secretary: Dr. Ganesh Subramanian Dec 2021 – Dec 2024

•Deputy Secretary: Dr Mary Joan MacLeod Dec 2021 – Dec 2024

•Treasurer: Dr Elizabeth Warburton

•External Engagement Lead : Dr Yvonne Chun

•Sustainability Lead: Dr Bethan Davies

•Equality Diversity and Inclusivity Lead: Dr Soma Banerjee

•Chair Scien�fic Subcommi�ee: Dr Abhijit Das

•Chair Training and Educa�on Subcommi�ee: Dr Louise Shaw •Chair Clinical Standards Subcommi�ee: Dr Michelle Dharmasiri

•Chair Trainee Subcommi�ee: Dr Isuru Induruwa

•Execu�ve Member represen�ng Wales: Dr Tom Hughes •Execu�ve Member represen�ng Northern Ireland: Dr Patricia Fearon •Execu�ve Member represen�ng Scotland Member: Dr Terry Quinn •Execu�ve Member represen�ng England Member: Dr Melanie Blake •Execu�ve Member represen�ng England Member: Dr Becky Jupp

•Execu�ve Member represen�ng Republic of Ireland: Prof Margaret O’Connor

Scientific Subcommittee April 2022– March 2023

•Chairman: Dr Abhijit Das (Jan 23)

•Chairman: Prof Craig Smith (Dec 20 – Dec 23)

•Member: Prof Craig Smith (Jan 23) •Member: Dr Will Whiteley •Member: Dr Phil Clatworthy

•Member: Dr Jonathan Hewi�

•Member: Alastair Webb

•Member: Dr Abhijit Das (Apr 22 – Dec 23)

•Trainee Representa�ve: Dr Gordon Blair (Sept 22 – April 23)

•Trainee Representa�ve: Dr Linxin Li (stepped down Sept 22)

2

British and Irish Association of Stroke Physicians Company Limited by Guarantee Trustees' Annual Report (Incorporating the Director's Report) (continued) For the year ended 31 March 2023

Clinical Standards Subcommittee April 2022– March 2023 •Chairman: Dr. Michelle Dharmasiri •Member: Dr Kath Pasco

•Member: Dr Ja� Khaira

•Member: Dr James Richard G Marigold

•Member: Dr Eiman Abdelgadir

•Member: Dr Kamy Thavanesan •Member: Dr Joseph Kwan (Jan 23) •Co-opted Member: Dr Fergus Doubal •Co-opted Member: Dr Ivan Wiggam (Dec 19 – Dec 22)

•Trainee Representa�ve: Dr Ahmed Gabr (Jul 22)

Training & Education Subcommittee April 2022 – March 2023 •Chairman: Dr Louise Shaw

•Member: Dr James Choulerton

•Member: Dr Saugata Das

•Member: Dr Senthil Raghunathan (Dec 22)

•Member: Dr Sarita Sochart (Dec 22)

•Member: Dr Jessica Beavan (Dec 22)

•Member: Dr Kirsty Harkness (Dec 16 – Dec 22)

•Member: Dr Kailash Krishnan (Dec 18 – Oct 22

•Member: Dr Sunil Munshi (Dec 16 – Oct 22)

•Trainee Representa�ve: Dr David McShane (Mar 22)

•Trainee Representa�ve: Dr Timothy Atkinson (Mar 22)

Trainee Subcommittee April 2022 – March 2023 •Chairman: Dr Isuru Induruwa (Aug 21 – Mar 23)

•Member: Dr Lixin Li (Dec 19 – Sept 22)

•Member: Dr Gordon Blair (Sept 22)

•Member: Dr Joseph Pybus (Sept 22)

•Member: Stewart McKenna (Sept 22)

•Member: Shyam Kelavkar (Sept 22)

•Member: Dr Karina Benne�( Sept 22)

•Member: Dr Nevan Joyce (Dec 20 – Aug 22)

•Member: Dr Ahmed Gabr

•Member: Dr Alan Cameron

•Member: Dr David McShane

•Member: Dr Timothy Atkinson

3

British and Irish Association of Stroke Physicians

Company Limited by Guarantee Trustees' Annual Report (Incorporating the Director's Report) (continued) For the year ended 31 March 2023

BIASP Overview

BASP consulted its members in 2021 regarding adding the Republic of Ireland to the Association name and activities. It was voted in favor by members. BASP (British Association of Stroke Physicians) amended its name to BIASP (British and Irish Association of Stroke Physicians following the December 2021 AGM.

The British Association of Stroke Physicians (BASP) was established in 1999 to promote the adv ancementof stroke medicine within Great Britain. Our members are all practicing doctors who care for patients with stroke, with the aim of prov idingthe highest standard of care. We v alueour diverse membership including physicians from a range of backgrounds and clinical roles. Some stroke physicians look after patients throughout the pathway, while others have expertise in a particular specialist area. Some stroke physicians provide care exclusively for patients with TIA/stroke, whilst others provide care to patients from their parent specialty: for example, general medicine, geriatric medicine, neurology or rehabilitation medicine. Many of our members have academic roles in stroke research. Our members also contribute to continuously improving the quality of stroke care according to the best available evidence.

BIASP was formed with a less than full-time administrator and a modest membership fee. Over almost two decades, BIASP has made considerable progress. The membership has grown. Scientific meetings have occurred every year. BIASP was a founding major coalition partner in the UK Stroke Forum, and the BIASP annual scientific meeting has merged into the UK Stroke Forum coalition’s annual conference. BIASP participated in developing and leading the NIHR stroke research network. BIASP members participated in developing and delivering major evidence-based improvements in the care of people with stroke and at risk of stroke. BIASP also helped to establish stroke medicine as a sub-speciality. During this time, an elected, un-paid executive committee has directed and conducted BIASP’s activities. This BIASP executive committee currently comprises 18 people: President, Past President, President Elect, Honorary Secretary, Deputy Honorary Secretary, Honorary Treasurer, External Engagement Lead, Sustainability Lead, Equality, Div ersityand Inclusion Lead, Scientific subcommittee chair, Trainees subcommittee chair, Training and Education subcommittee chair, Clinical Standard subcommittee chair, National Representatives (one for Wales, Scotland, and Northern Ireland, Republic of Ireland and two for England).

The BIASP executive committee is supported by members of the subcommittees.

BIASP strategic direction

BIASP’s mission of ‘advancing stroke medicine’ for the good of the public, patients and professionals is guided by a strategic plan, a new plan was put in place for 2021 - 2024.

During the spring and summer of 2020, the BASP executive committee chairs and BASP President reviewed BASP’s progress and execution of the aims of the BASP strategy during 2017-2020. We found clear evidence of satisfying almost all of the aims of the BASP strategy 2017-2020.

Following this review of the execution of the 2017-2020 strategy, the president drafted this quadrennial update of the strategic plan with input from the executive committee (18 May – 6 October 2020). The president created the final version of the strategic plan 2021-2024 following a consultation with the public (via the BIASP website), relevant stroke organisations (who were alerted via email) and BIASP full, associate, and retired members between 6-30 October 2020.

The consultation yielded responses from five organisations (Intercollegiate Stroke Working Party, Different Strokes, Association of British Neurologists stroke advisory group, British Cardiovascular Society, and The Stroke Association) and 17 individuals via an online form or email. This strategic plan 2021-2024 was launched after the president presented it at the annual general meeting on 8 December 2020.

The BIASP strategy 2021 - 2024 included five main areas of focus:

•Clinical Standards Service •Teaching and Training •Research •External Engagement

•Administra�on of the Associa�on

Each of these areas has a number of defined objectives, these can be viewed via the strategy hosted on the BIASP website.

Moving Forward

All future actions are aligned with the 2021 – 2024 strategy. The 2025 – 2028 strategy will be developed.

BIASP are members of:

•World Stroke Organisa�on (WSO)

•European Stroke Organisa�on (ESO)

•Neurological Alliance

•Community rehabilita�on alliance (CRA), joined 22/03/2022

4

British and Irish Association of Stroke Physicians Company Limited by Guarantee Trustees' Annual Report (Incorporating the Director's Report) (continued) For the year ended 31 March 2023

BIASP Meetings

The BIASP Executive meets monthly, three times during the year this is a 4-hour meeting, the other meetings last for one hour. The Executive oversee and provide direction to the Association, to determine the Association's strategy and support the work undertaken by the subcommittees. The subcommittees meet virtually, on a quarterly basis.

BIASP have been working to develop closer relationships with other professional organisations including BGS (reciprocal joint membership reduction 20% discount for first year of membership), ABN, BSRM, SAM, through regular meetings with the other societies’ executives.

BIASP chair quarterly 5 Nation meetings. The clinical leads from each nation, BIASP executiv e leads for each nation and charities such as the Stroke Association, Different Strokes, Chest Heart & Stroke Scotland, Irish Heart Foundation and Northern Ireland Chest Heart &Stroke and British Heart Foundation are invited. A different topic is chosen for discussion each month with each participant sharing views.

BIASP are working with Covid -19 Airborne Transmission Alliance (CATA) and providing information for the UK-public inquiry into Covid.

BIASP Committee representation

BIASP also has formal representation on external committees. These are listed here:

Joint Neurosciences Council
Trainingand Education
Stroke Action Plan for Europe(SAP-E)
Clinical Standards Chair
Cross PartyWorkingGroupon Stroke
Scotland Representative and BIASP President
Intercollegiate Stroke
BIASP President-elect
Joint Stroke Medicine Committee
BIASP President Elect & BIASP Trainee
NHSE&I Stroke DeliveryBoard
England Representative
Group
BIASP Representative
Association of British Neurologists
BIASP President Elect & ABN SIG member
Joint Clinical
England Representative x2,trainee committee chair
NIHR Stroke National SpecialtyGroup
Scientific Committee Chair
NI Stroke Network
Northern Ireland Representative		 Joint Neurosciences Council
Trainingand Education
Stroke Action Plan for Europe(SAP-E)
Clinical Standards Chair
Cross PartyWorkingGroupon Stroke
Scotland Representative and BIASP President
Intercollegiate Stroke
BIASP President-elect
Joint Stroke Medicine Committee
BIASP President Elect & BIASP Trainee
NHSE&I Stroke DeliveryBoard
England Representative
Group
BIASP Representative
Association of British Neurologists
BIASP President Elect & ABN SIG member
Joint Clinical
England Representative x2,trainee committee chair
NIHR Stroke National SpecialtyGroup
Scientific Committee Chair
NI Stroke Network
Northern Ireland Representative		 Joint Neurosciences Council
Trainingand Education
Stroke Action Plan for Europe(SAP-E)
Clinical Standards Chair
Cross PartyWorkingGroupon Stroke
Scotland Representative and BIASP President
Intercollegiate Stroke
BIASP President-elect
Joint Stroke Medicine Committee
BIASP President Elect & BIASP Trainee
NHSE&I Stroke DeliveryBoard
England Representative
Group
BIASP Representative
Association of British Neurologists
BIASP President Elect & ABN SIG member
Joint Clinical
England Representative x2,trainee committee chair
NIHR Stroke National SpecialtyGroup
Scientific Committee Chair
NI Stroke Network
Northern Ireland Representative
BIASP Repre sentative
BIASP President Elect & ABN SIG member
England Representative x2,trainee committee chair
Trainingand Education
Clinical Standards Chair
Scotland Representative and BIASP President
BIASP President-elect
BIASP President Elect & BIASP Trainee
England Representative
Scientific Committee Chair
Northern Ireland Representative
S cotland Stroke Research Network Scotland Representative

BIASP Committee representation (continued)

SPCommittee representation (continued)
UKSF SteeringCommittee
UKSF Scientific Programme Committee
Wales Association for Stroke Physicians
5 Nations Meetings
Neurological Alliance
UKHACC Council
CommunityRehabilitation Alliance
Stroke SpecialityAdvisoryCommittee
Royal College of Radiologists MT
National AdvisoryCommittee for Stroke
RCP Medical Specialties Board
NICE Stroke rehabguidance		 BIASP President
Scientific Committee Chair
Wales Representative
Trainingand Education
Clinical Standards Chair
Scotland Representative
BIASP President
Scientific subcommittee member
BIASPpresident(or BIASP Past President or BIASP
BIASP Past-President
BIASP President or BIASP Past-President,Sustainability
Clinical Standards Representative

Scientific Subcommittee

The Scientific subcommittee have been working on the following areas which align with the BIASP strategic plans:

The scientific committee is actively involved in the planning of the programme for the next UKSF.

BIASP/NIHR Writing groups are supported through a grant from BIASP (£5,000).

5

British and Irish Association of Stroke Physicians

Company Limited by Guarantee

Trustees' Annual Report (Incorporating the Director's Report) (continued) For the year ended 31 March 2023

Training & Education Subcommittee

Training & Education Subcommittee:

The Training & Education Subcommittee have been involved in the following activities in addition to it’s duty to the UKSF:

The priorities for the Training & Education Subcommittee have been:

Take up Stroke Fellows:

The Training and Education committee to be responsible for running monthly free webinars. These recordings are then made available to members post webinar via the BIASP website.

Clinical Standards Subcommittee

The Clinical Standards Subcommittee have been working on the following activities:

Trainee Subcommittee

The Trainee Subcommittee have been working on the following activities:

planning to engage at high school level to give an understanding of what a career in stroke means

6

British and Irish Association of Stroke Physicians Company Limited by Guarantee Trustees' Annual Report (Incorporating the Director's Report) (continued)

For the year ended 31 March 2023

Bursaries and competitions

Warlow Prize

The winner of the BIASP Warlow Prize 2022 was awarded a certificate and receiv es support to attend the annual conference of the European Stroke Conference in order to present their prize-winning research.

BIASP President’s Award

In celebration of BASP’s 20th Anniversary in 2019, we introduced an annual ‘President’s Award’ to reward excellence in clinical standards (including clinical practice and/ or quality improvement), training and education, and/ or research related to Stroke Medicine.

BIASP members are asked to nominate a UK Stroke Physician, who is a BIASP member, and demonstrates excellence in clinical standards (including clinical practice and/or quality improvement), training and education, and/ or research related to Stroke Medicine.

BIASP Medical Student Essay Prize

Entrants must submit 250-word case report on a patient they have seen or been inv olv edwith that has suffered a stroke and they hav e an important message to tell. The prize for the winner is free attendance at the BIASP Trainees’ meeting with the opportunity to present their case.

BIASP/NIHR Writing Group Applications

Each year, the BIASP and the NIHR CRN:Stroke jointly issue a call to doctors, nurses and allied health professionals for writing groups to support portfolio development across the stroke pathway. A maximum of £2,000 per writing group is available, and The Stroke Association have kindly agreed to offer their premises across the United Kingdom to facilitate these writing group meetings. Usually up to two applications are funded, following peer rev iew by representatives of the BIASP scientific committee, NIHR CRN:Stroke National Specialty Group and other invited reviewers.

BIASP Innovation in Sustainable Stroke Care Competition

This competition is to champion innovative ideas that can contribute to the development of greener, more sustainable stroke care. The competition is open to all junior doctors (foundation year doctors, GP trainees, clinical fellows, higher specialty trainees) and allied health professionals. You do not need to be a BIASP member to apply.

The winner will receive a funded place to attend the Centre for Sustainable Healthcare’s Sustainable Quality Improvement (SusQI) course and applications that lead to completed projects will be encouraged to submit abstracts for presentation at the forthcoming UK Stroke Forum.

UK Stroke Forum 2022

UKSF yearly conference in Liverpool in 2022 hosted by Stroke Association and BIASP. Joint session was run with BGS at UKSF 2022. BIASP are represented at the UKSF Steering Committee meetings and the UKSF Scientific Programme committee.

Ukraine

To support colleagues displaced by the war in Ukraine BIASP now offer free membership which allows access to all information on the BIADSP website.

Financial review

The charity's incoming resources for the year were £139,569 (2022: £83,281) mainly comprising subscription income of £94,486 (2022: £78,312) and conference registrations of £24,959 (2022: £1,405). Spending in support of charitable activities was £114,447 (2022: £99,350). Support related costs were £63,156 (2022: £60,678). Governance fees were

£4,120 (2022: £3,360). Net surplus for the year of £25,122 (2022: net deficit £16,069). Reserves and funds carried forward at 31 March 2023 were £266,660 (2022: £241,538).

Reserves policy

Currently BIASP is required to retain a significant liquid capital reserve to be able to discharge its obligations in underwriting the UK Stroke Forum (see below) without jeopardizing its other activities.

Investment policy

The Honorary Treasurer shall deposit or invest any funds which are not immediately required for the Company's activities in such investments as may be considered appropriate (and to dispose of, and vary, such investments) which may include investing in one or more collective investment scheme(s), such as unit trusts, open ended investment companies or common investment funds for charities. In keeping with the BIASP strategy aims any such investments will be scrutinized to ensure these are compatible climate sustainability.

Risk management

The Trustees annually review the risks that the charity faces. To date these have mainly related to the Association's joint underwriting of the UK Stroke Forum. This is the premier educational academic and clinical stroke conference in the UK. It seeks to bring together members from medicine, nursing, the therapies and other healthcare professionals to share knowledge and enhance practice in stroke medicine. The association is responsible for 1/3 of the profit or loss of the overall result from UKSF. Due to increasing costs and events during covid this has resulted in BIASP being responsible for a share of the loss on recent events. The overall conference result is monitored closely by the UKSF steering committee of which BIASP is represented on.

7

British and Irish Association of Stroke Physicians

Company Limited by Guarantee Trustees' Annual Report (Incorporating the Director's Report) (continued) For the year ended 31 March 2023

Future plans

The Association remains strategically committed to furthering its broad objectives by whatever appropriate means in accordance with its charitable status. The profile of stroke medicine in the UK has risen sharply, supported by political initiatives such as the English National Stroke Strategy and the equivalent policy documents in the devolved nations of the UK. With this rising profile is a corresponding demand upon the Association to put forward the views of the profession to political bodies, other healthcare professions and the wider public; to liaise with an increasing number of interested national bodies; to support and develop the scientific credibility of the practice of stroke medicine; and to improve the training of physicians in stroke medicine. These demands will continue or increase in the years to come, drawing on the financial and other resources of the Association.

Equality Diversity and Inclusion is already in the BIASP strategy, and we wish to accelerate progress in this area, first by focusing on the processes of the society, and then by exploring EDI in the wider stroke workforce. The advertisement for the EDI representative is now open.

Trustee’s responsibilities statement:

The trustees, who are also directors for the purposes of company law, are responsible for preparing the trustees' report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice). Company law requires the charity trustees to prepare financial statements for each year which give a true and fair view of the state of affairs of the charitable company and the incoming resources and application of resources, including the income and expenditure, for the period. In preparing these financial statements, the trustees are required to:

The trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the charity's transactions and disclose with reasonable accuracy at any time the financial position of the charity and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Small company provisions

This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies’ exemption. The trustee’s annual report was approved on and signed on behalf of the board of trustees by: -

Gillian Mead Trustee & President

8

Company Limited by Guarantee Independent examiner’s report

British and Irish Association of Stroke Physicians

For the year ended 31 March 2023

I report to the charity trustees on my examination of the financial statements of the Charity for the year ended 31 March 2023.

Respective responsibilities of trustees and examiner

As the charity’s trustees of the Company (and its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 (‘the 2006 Act’).

Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity’s accounts as carried out under section 145 of the Charities Act 2011 (‘the 2011 Act’). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5) (b) of the 2011 Act.

Basis of independent examiner’s report

My examination was carried out in accordance with the general Directions given by the Charity Commission. An examination includes a review of the accounting records kept by the charity and a comparison of the accounts presented with those records. It also includes consideration of any unusual items or disclosures in the accounts, and seeking explanations from you as trustees concerning any such matters. The procedures undertaken do not provide all the evidence that would be required in an audit and consequently no opinion is given as to whether the accounts present a ‘true and fair view’ and the report is limited to those matters set out in the statement below.

Independent examiner’s qualified statement

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.

Use of our report

This report is made solely to the charitable company’s members and the trustees, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our examination has been undertaken so that we might state to the charitable company’s members those matters we are required to state to them in an independent examiner’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company, the charitable company’s members and trustees as a body, for our examination, for this report, or for the opinions we have formed.

Kenneth McDowell CA Saffery Champness LLP Chartered Accountants

Edinburgh Quay 133 Fountainbridge Edinburgh EH3 9BA

9

British and Irish Association of Stroke Physicians

Company Limited by Guarantee

Statement of Financial Activities (including Income and Expenditure account) For the year ended 31 March 2023

Notes
Income and endowments
Income from donations and legacies
3
Investment income
4
Charitable activities
5
Total income
Expenditure on:
Charitable activities
6
Total expenditure
Net (expenditure)/income
Transfers between funds
Total funds brought forward
Total funds carried forward
10		 Unrestricted
funds
£
-
764
138,805
139,569
114,447
114,447
25,122
-
241,538
266,660		 Total funds
2023
£
-
764
138,805
139,569
114,447
114,447
25,122
-
241,538
266,660		 Total funds
2022
£
75
-
83,206
83,281
99,350
99,350
(16,069)
-
257,607
241,538

The statement of financial activities includes all gains and losses recognised in the year.

All income and expenditure derive from continuing activities.

10

British and Irish Association of Stroke Physicians Company Limited by Guarantee Statement of financial position For the year ended 31 March 2023

Notes
Current assets
Debtors
8
Cash at bank and in hand
Creditors: amounts falling due within one year
9
Net current assets
Total assets less current liabilities
Net assets
Funds of the charity
Unrestricted funds
10		 2023
£
£
35,108
295,437
330,545
-
63,885
266,660
266,660
266,660
266,660
266,660		 2022
£
£
4,813
301,764
306,577
-
65,039
241,538
241,538
241,538
241,538
241,538		 2022
£
£
4,813
301,764
306,577
-
65,039
241,538
241,538
241,538
241,538
241,538
241,538
241,538
241,538
241,538

For the financial year ended 31 March 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The trustees acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime.

The financial statements were approved by the board of trustees and authorised for issue on XX-XXX-XX and are signed on its behalf by:

Professor Rustam Al-Shahi Salman

Trustee & President Company Registration No. 06853971

11

British and Irish Association of Stroke Physicians Company Limited by Guarantee Notes to the financial statements For the year ended 31 March 2023

1. Accounting Policies

Company information

The charity is a private company limited by guarantee, registered in England and Wales and a registered charity in England. The address of the registered office is 71 Queen Victoria Street, London, England, EC4V 4BE.

The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019) - Charities SORP (FRS 102), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.

The charity meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy notes.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

1.2 Going Concern

At the time of approving the financial statements, the trustees have a reasonable expectation that the charity has adequate resources to continue in operational existence for the foreseeable future. Thus the trustees continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3 Income and expenditure

Income representing membership subscriptions, interest and branch income receivable is accounted for on an accruals basis. Donations and gift aid claims are recognised on receipt of proceeds.

Resources expended are included in the statement of financial activities on an accruals basis.

All costs have been directly attributed to one of the functional categories of resources expended in the statement of financial activities as follows:

Charitable activities

These are costs relating to expenditure on preserving and maintaining the assets of the charity and the associated trade.

Other expenditure

These are costs associated with the running of the regional branches of the charity.

1.4 Cash and cash equivalents

Cash at bank and in hand are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

12

British and Irish Association of Stroke Physicians Company Limited by Guarantee Notes to the financial statements For the year ended 31 March 2023

1.5 Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including trade and other creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as 'creditors: amounts falling due within one year' if payment is due within one year or less. If not, they are presented as 'creditors: amounts falling due after more than one year'. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Derecognition of financial liabilities

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

1.6 Fund accounting

The funds of the charity are held in unrestricted and restricted funds. Unrestricted funds represent funds which can be used in accordance with the charitable objectives at the discretion of the trustees. Restricted funds represent funds which must be used in accordance with the specific objectives that were laid out by those parties providing the funds to the charity.

13

British and Irish Association of Stroke Physicians Company Limited by Guarantee Notes to the financial statements For the year ended 31 March 2023

1. Accounting Policies (continued)

1.7 Taxation

The company is a registered charity and is not liable for United Kingdom income tax or corporation tax on charitable activities.

2. Limited by guarantee

British Association of Stroke Physicians is a company limited by guarantee and accordingly does not have share capital. Every member of the company undertakes to contribute such amount as may be required not exceeding £1 to the assets of the charitable company in the event of its being wound up while he or she is a member, or within one year after he or she ceases to be a member.

3. Income from donations and legacies

3. Income from donations and legacies
Donations
Paypal giving
Bank interest
Membership subscriptions
Conference
Trainee conference
5. Charitable activities
4. Investment income		 2023
£
-		 2022
£
75
- 75
2023
£
764		 2022
£
-
764 -
2023
£
94,486
24,959
19,360		 2022
£
78,316
1,405
3,485
138,805 83,207

14

British and Irish Association of Stroke Physicians Company Limited by Guarantee Notes to the financial statements

For the year ended 31 March 2023

6. Expenditure on charitable activities

6. Expenditure on charitable activities
Charitable activities
Conference
UKSF risk share
Subscriptions
Events
Advertising
Website
Trainee conference
Sponsorships and bursaries
Travel & subsistence
Donations
Insurance
Printing, postage, advertising & stationery
Share of support costs
Share of governance
Note 7
Support costs
Bank charges
Professional fees
Administrative costs
Bookkeeping
Fees payable to the independent examiner for:
Independent examination of the financial statements
Trade debtors
Prepayments
8. Debtors
7. Independent examination fees		 2023
£
-
3,699
-
1,458
1,641
3,690
20,009
15,042
77
-
1,544
12
63,156
4,120		 2022
£
-
1,352
-
244
1,120
7,362
10,965
14,085
-
-
157
30
60,677
3,360
114,447 99,350
1,027
16
54,525
7,588		 901
2,773
50,035
6,969
63,156 60,678
2023
£		 2022
£
4,120 3,360
2023
£
1,350
33,758		 2022
£
1,500
3,313
35,108 4,813

15

British and Irish Association of Stroke Physicians Company Limited by Guarantee Notes to the financial statements For the year ended 31 March 2023

9. Creditors: amounts falling due within one year

9. Creditors: amounts falling due within one year
Trade creditors
Accruals & deferred income
Analysis of deferred income account
Memberships
Conference receipts		 2023
£
8,043
55,842		 2022
£
24,846
40,193
63,885 65,039
36,623
-		 30,197
-
36,623 30,197

During the year brought forward deferred income of £30,197 was released to the statement of financial activities and a further £36,623 of income was deferred.

10. Analysis of charitable funds

10. Analysis of charitable funds
General funds
Unrestricted funds		 As at 1 April 2022
Income
Expenditure
£
£
£
241,538
139,569
(114,447)		 As at 31
March 2023
£
266,660
241,538
139,569
(114,447)		 266,660

11. Transactions with trustees

No trustees received remuneration in the year.

Travel and subsistence expenses reimbursed to trustees or paid directly to third parties totalled £Nil (2021: £Nil).

16

British and Irish Association of Stroke Physicians Company Limited by Guarantee Notes to the financial statements

For the year ended 31 March 2023

12. Analysis of net assets between funds

12. Analysis of net assets between funds
Current assets
Creditors less than 1 year
Net assets
Comparative analysis of net assets between funds for prior year
Current assets
Creditors less than 1 year
Net assets
Income and endowments
Income from donations and legacies
Charitable activities
Total income
Expenditure on:
Expenditure on charitable activities
Total expenditure
Net expenditure
Transfers between funds
Net movement in funds
Reconciliation of funds
Total funds brought forward
Total funds carried forward
13. Comparative Statement of Financial Activities for the year ended 31 March 2022		 Unrestricted funds
£
330,545
(63,885)		 Total Funds
2023
£
330,545
(63,885)
266,660 266,660
Unrestricted funds
£
306,577
(65,039)		 Total Funds
2022
£
306,577
(65,039)
241,538 241,538
Unrestricted funds
£
75
83,206		 Total funds
2022
£
75
83,206
83,281 83,281
99,350 99,350
99,350 99,350
(16,069) (16,069)
- -
(16,069)
257,607		 (16,069)
257,607
241,538 241,538

17

British and Irish Association of Stroke Physicians Company Limited by Guarantee Notes to the financial statements For the year ended 31 March 2023

14. Company limited by guarantee

The charity is a company limited by guarantee and has no share capital. The liability of each member in the event of winding up while he or she is a member, or within one year after he or she ceases to be a member, is limited to £1.

15. Post balance sheet events and going concern

At the date of approval, the trustees have prepared and approved up to date management accounts, and have also considered future cash flow including key income and cost assumptions that the trustees consider reasonable and prudent.

Having considered the matters above the trustees are of the view that, at the date of approval of the financial statements, the charity will have sufficient resources to continue to operate and meet debts as they fall due for the foreseeable future. The financial statements have therefore been drawn up on a going concern basis.

18